USFDA approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
The Loratadine Tablets are used in the treatment of symptoms like itching, runny nose, watery eyes, and sneezing caused by ‘hay fever’ and other allergies.
Marksans Pharma receives USFDA approval for Loratadine Tablets USP 10 mg, expanding its generic drug portfolio.